Assessment of the development of assisted reproductive technology in Liaoning province of China, from 2012 to 2016

被引:17
作者
Fang, Yuan-Yuan [1 ]
Wu, Qi-Jun [2 ]
Zhang, Tie-Ning [3 ]
Wang, Tian-Ren [4 ]
Shen, Zi-Qi [1 ]
Jiao, Jiao [1 ]
Shao, Xiao-Guang [5 ]
Xu, Peng [6 ]
Guo, Shuai-Shuai [7 ]
Zhou, Yi-Ming [8 ]
Wang, Xiu-Xia [1 ]
Li, Da [1 ]
机构
[1] China Med Univ, Shengjing Hosp, Dept Obstet & Gynecol, Ctr Reprod Med, Shenyang 110004, Liaoning, Peoples R China
[2] China Med Univ, Dept Clin Epidemiol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R China
[3] China Med Univ, Dept Pediat, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R China
[4] Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA
[5] Dalian Municipal Womens & Childrens Med Ctr, Reprod & Genet Med Ctr, Dalian 116031, Peoples R China
[6] Jinghua Hosp, Ctr Human Reprod & Genet, Shenyang 110000, Liaoning, Peoples R China
[7] Shenyang Womens & Childrens Hosp, Ctr Reprod Med, Shenyang 110011, Liaoning, Peoples R China
[8] Harvard Med Sch, Harvard Inst Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
来源
BMC HEALTH SERVICES RESEARCH | 2018年 / 18卷
基金
中国国家自然科学基金;
关键词
Assisted reproduction techniques; In vitro fertilization; Time trend; Liaoning province; China;
D O I
10.1186/s12913-018-3585-9
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BackgroundThe development of assisted reproduction techniques (ART) has resulted in rapid advances in the treatment of infertility. However, a systematic assessment of ART and its processes and outcomes in China has never been carried out. The goal of this study was to assess the features of ART status from 2012 to 2016 in clinics and in vitro fertilization (IVF) laboratories in Liaoning, the largest IVF province in the northeast of China.MethodsData from Jan 1, 2012 to Dec 31, 2016 was retrieved from the assisted reproductive certificate registry of Liaoning province. We extracted data from: i) fresh and thawed cycles; ii) donor sperm and donor egg cycles; iii) intrauterine insemination with husband semen and donor semen (AIH and AID).ResultsWe showed that: (i) there has been a significant increase in the number of IVF fresh and thawed cycles, and the proportion of cases of primary infertility and secondary infertility has decreased and increased, respectively; (ii) standard long GnRH agonist was the major ovarian stimulation protocol. During the observation period, increasing trends in the use of GnRH antagonists, mild stimulation, and natural cycles were observed; (iii) significant differences in the number of cycles, number of retrieved oocytes, fertilization rates, implantation rates, and sex ratio were noticed between conventional IVF and intracytoplasmic sperm injection; (iv) significant differences in age at treatment for infertility, number of cycles, and ectopic pregnancy rates were noticed between donor sperm cycles and donor egg cycles; (v) significant differences in number of thawed cycles, number of thawed embryos, embryo recovery rates, implantation rates, and clinical pregnancy rates were noticed between day 3 and day 5 embryos; (vi) significant differences in age at treatment for infertility, number of cycles, clinical pregnancy rates, ectopic pregnancy rates, and live birth ratio were noticed between AIH and AID.ConclusionsART in Liaoning province has undergone substantial development from 2012 to 2016 in clinics and IVF laboratories. This presentation of detailed ART data will provide researchers, policy makers, and potential ART users a rich source of information about IVF characteristics in the northeast of China.
引用
收藏
页数:10
相关论文
共 12 条
  • [1] Life-style factors and female infertility
    Buck, GM
    Sever, LE
    Batt, RE
    Mendola, P
    [J]. EPIDEMIOLOGY, 1997, 8 (04) : 435 - 441
  • [2] Little Emperors: Behavioral Impacts of China's One-Child Policy
    Cameron, L.
    Erkal, N.
    Gangadharan, L.
    Meng, X.
    [J]. SCIENCE, 2013, 339 (6122) : 953 - 957
  • [3] ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
    Ferraretti, A. P.
    La Marca, A.
    Fauser, B. C. J. M.
    Tarlatzis, B.
    Nargund, G.
    Gianaroli, L.
    [J]. HUMAN REPRODUCTION, 2011, 26 (07) : 1616 - 1624
  • [4] Final ART success rates: a 10 years survey
    Gnoth, C.
    Maxrath, B.
    Skonieczny, T.
    Friol, K.
    Godehardt, E.
    Tigges, J.
    [J]. HUMAN REPRODUCTION, 2011, 26 (08) : 2239 - 2246
  • [5] Changing trends in the prevalence of anencephaly in Liaoning province of Northeast China from 2006-2015: data from a population-based birth defects registry
    Gong, Ting-Ting
    Wu, Qi-Jun
    Chen, Yan-Ling
    Jiang, Cheng-Zhi
    Li, Da
    Li, Jing
    Li, Li-Li
    Zhou, Chen
    Huang, Yan-Hong
    [J]. ONCOTARGET, 2017, 8 (32) : 52846 - 52853
  • [6] Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century
    Inhorn, Marcia C.
    Patrizio, Pasquale
    [J]. HUMAN REPRODUCTION UPDATE, 2015, 21 (04) : 411 - 426
  • [7] An assessment of lifestyle modification versus medical treatment with clomiphene citrate, metformin, and clomiphene citrate-metformin in patients with polycystic ovary syndrome
    Karimzadeh, Mohammad Ali
    Javedani, Mojgan
    [J]. FERTILITY AND STERILITY, 2010, 94 (01) : 216 - 220
  • [8] Assisted reproductive technology in China: compliance and non-compliance
    Qiao, Jie
    Feng, Huai L.
    [J]. TRANSLATIONAL PEDIATRICS, 2014, 3 (02): : 91 - 97
  • [9] Effectiveness of lifestyle intervention in subgroups of obese infertile women: a subgroup analysis of a RCT
    van Oers, A. M.
    Groen, H.
    Mutsaerts, M. A. Q.
    Burggraaff, J. M.
    Kuchenbecker, W. K. H.
    Perquin, D. A. M.
    Koks, C. A. M.
    van Golde, R.
    Kaaijk, E. M.
    Schierbeek, J. M.
    Oosterhuis, G. J. E.
    Broekmans, F. J.
    Vogel, N. E. A.
    Land, J. A.
    Mol, B. W. J.
    Hoek, A.
    [J]. HUMAN REPRODUCTION, 2016, 31 (12) : 2704 - 2713
  • [10] Wahlberg Ayo, 2016, Reprod Biomed Soc Online, V2, P97, DOI 10.1016/j.rbms.2016.09.002